NHS to lose out on new drugs, pharma firm warns

NHS to lose out on new drugs, pharma firm Novartis warns

The claims from pharmaceutical giant Novartis comes amid a row over drug pricing deals.

Britain has missed out on billions of pounds over NHS pricing row, says drugs giant

Novartis boss claims outdated policies making UK ‘uninvestable’

UK Pharma Investment Warning: Novartis Calls Country "Uninvestable" - News and Statistics

A Novartis executive warns the UK's drug pricing policies have made the country uninvestable, leading to missed investments and delayed access to new medicines.

Big Pharma Blackmail: How the NHS Is Paying the Price

Share this post: The row between "big pharma" company Novartis, the government, and the NHS over the cost of new drugs is not just another “technical” disagreement about rebates and thresholds. It is a test of who really runs Britain’s health system: elected representatives acting in the public interest, or multinational corporations prepared [...] The post Big Pharma is blackmailing the government – and the NHS is paying the price appeared firs…